In agreement with earlier results [22], HCC tumors of grade II and III, exhibited a statistically significant reduction in the number of hepatocytes with DDX5-positive immunostaining compared to normal liver tissue (Fig. 1A, B and Supplementary Figs. S1A–S3). Here, DDX5 is linked to hepatocellular carcinoma.